» Articles » PMID: 39462910

Comparison of Extracorporeal and Intracorporeal Urinary Diversion After Robot-Assisted Radical Cystectomy for Bladder Cancer: A Meta-Analysis

Overview
Date 2024 Oct 28
PMID 39462910
Authors
Affiliations
Soon will be listed here.
Abstract

To explore the therapeutic efficacy of intracorporeal urinary diversion (ICUD) and extracorporeal urinary diversion (ECUD) after robot-assisted radical cystectomy for bladder cancer through systematic review. This study systematically retrieved electronic databases of PubMed, Web of Science, Cochrane Library, CNKI, and Wanfang to include peer-reviewed studies comparing ICUD and ECUD after robot-assisted radical cystectomy for bladder cancer. Relative risk (RR) and mean difference (MD) were used to represent the pooled effect size and estimate its 95% confidence interval (CI). This study included 15 studies with good quality, involving 5,370 patients undergoing robot-assisted radical cystectomy for bladder cancer. Meta-analysis showed that ICUD reduced intraoperative bleeding volume by 64.12 ml (95% confidence interval [CI]: [-100.95, -27.29]), significantly decreased the risk of blood transfusion (RR: 0.40; 95% CI: [0.24, 0.68]) and gastrointestinal complications (odds ratio []: 0.61; 95% CI: [0.47, 0.80]), with shorter postoperative time of exhaust (MD: -9.27; 95% CI: [-18.47, -0.08]) and oral intake (MD: -0.92; 95% CI: [-1.30, -0.54]). However, ICUD had a relatively longer surgical duration (MD: 30.84 min, 95% CI: [5.03, 56.66]). In addition, there was no statistically significant difference concerning the impact of ICUD and ECUD on the length of stay in the hospital (MD: -0.68d; 95% CI: [-1.79, 0.42]), overall complications (30-day: RR: 1.16; 95% CI: [0.93, 1.46]; and 90-day, RR: 0.85; 95% CI: [0.69, 1.04]) and readmission rate (30-day: RR: 0.96; 95% CI: [0.72, 1.27]; and 90-day: RR: 1.15; 95% CI: [0.80, 1.64]). ICUD after robot-assisted laparoscopic radical cystectomy for bladder cancer exhibits obvious positive effects, especially in reducing the risk of blood transfusion and gastrointestinal complications, and shortening postoperative time of exhaust and oral intake. The findings in this meta-analysis should be confirmed by multiple high-quality studies in the future.

References
1.
Weber A, Vignat J, Shah R, Morgan E, Laversanne M, Nagy P . Global burden of bladder cancer mortality in 2020 and 2040 according to GLOBOCAN estimates. World J Urol. 2024; 42(1):237. PMC: 11021283. DOI: 10.1007/s00345-024-04949-8. View

2.
Pyun J, Kim H, Cho S, Kang S, Cheon J, Lee J . Robot-Assisted Radical Cystectomy with Total Intracorporeal Urinary Diversion: Comparative Analysis with Extracorporeal Urinary Diversion. J Laparoendosc Adv Surg Tech A. 2016; 26(5):349-55. DOI: 10.1089/lap.2015.0543. View

3.
Kingo P, Norregaard R, Borre M, Jensen J . Postoperative C-reactive protein concentration and clinical outcome: comparison of open cystectomy to robot-assisted laparoscopic cystectomy with extracorporeal or intracorporeal urinary diversion in a prospective study. Scand J Urol. 2017; 51(5):381-387. DOI: 10.1080/21681805.2017.1334698. View

4.
Bertolo R, Agudelo J, Garisto J, Armanyous S, Fergany A, Kaouk J . Perioperative Outcomes and Complications after Robotic Radical Cystectomy With Intracorporeal or Extracorporeal Ileal Conduit Urinary Diversion: Head-to-head Comparison From a Single-Institutional Prospective Study. Urology. 2019; 129:98-105. DOI: 10.1016/j.urology.2018.11.059. View

5.
Shim J, Kwon T, Rha K, Lee Y, Lee J, Jeong B . Do patients benefit from total intracorporeal robotic radical cystectomy?: A comparative analysis with extracorporeal robotic radical cystectomy from a Korean multicenter study. Investig Clin Urol. 2020; 61(1):11-18. PMC: 6946824. DOI: 10.4111/icu.2020.61.1.11. View